Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | 7gf79 | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | CX4H2 | IM / LA |
Received TdaP and menveo one day prior to onset. Localized swelling, mass and lump, unspecified.. It began yesterday. It is of moderate intensity. This is the first episode. The typical duration of an episode is the majority of the day. There are no obvious aggravating factors. Nothing relieves the symptoms. Associated symptoms include rash. He denies abdominal pain, arthralgias, chest pain, chills, constipation, cough, diarrhea, dysuria, fever, headache, hematuria, jaundice, melena, myalgias, nausea, palpitations, paresthesias, red bloody stools, sore throat, sweats, tachycardia, vomiting or weight loss.
ADHD, Sleep Issues, Constipation, Oppositional Defiant Behaviors
Vyvanse 40mb, Clonidine 0.1mg
NKDA